These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722 [TBL] [Abstract][Full Text] [Related]
6. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy. Crook J; Toi A; McLean M; Pond G Brachytherapy; 2002; 1(3):131-7. PubMed ID: 15090275 [TBL] [Abstract][Full Text] [Related]
7. Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapy. Thomas C; Keyes M; Liu M; Moravan V Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):447-55. PubMed ID: 18395357 [TBL] [Abstract][Full Text] [Related]
8. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy. Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062 [TBL] [Abstract][Full Text] [Related]